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Background: This study aimed to identify the systemic and cerebral hemodynamic characteristics and their roles in
high-altitude headache (HAH) among young Chinese men following acute exposure.
Methods: The subjects (n = 385) were recruited in June and July of 2012. They completed case report form questionnaires,
as well as heart rate (HR), blood pressure, echocardiogram and transcranial Doppler examinations at 3700 m
following a two-hour plane flight. A subgroup of 129 participants was examined at two altitudes (500 and 3700 m).
Results: HAH was characterized by increased HR and cardiac output (CO) and lower saturation pulse oxygen (SpO2) (all
p < 0.05). The change in tricuspid regurgitation was also different between the HAH positive (HAH+) and HAH negative
(HAH-) subjects. Furthermore, the HAH+ subjects exhibited faster mean (Vm), systolic (Vs) and diastolic (Vd) velocities in
the basilar artery (BA; all p < 0.05) and a faster Vd ( 25.96 ± 4.97 cm/s vs. 24.76 ± 4.76 cm/s, p = 0.045) in the left vertebral
artery (VA). The bilateral VA asymmetry was also significantly different between the two groups. The pulsatility index
(PI) and resistance index (RI) of left VA were lower in the HAH subjects (p < 0.05) and were negatively correlated with
HAH (p < 0.05). Baseline CO and Vm in left VA (or right MCA in different regressions) were independent predictors for
HAH, whereas CO/HR and ΔVd (Vd difference between bilateral VAs) were independent risk factors for HAH at 3700 m.
Conclusions: HAH was characterized, in part, by increased systemic hemodynamics and posterior cerebral circulation,
which was reflected by the BA and left VA velocities, and lower arterial resistance and compliance. Furthermore,
baseline CO and Vm in left VA or right MCA at sea level were independent predictors for HAH, whilst bilateral VA
asymmetry may contribute to the development of HAH at high altitude.
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High-altitude headache (HAH) is the primary critical
complaint after high altitude exposure [1]. It is defined
as a headache that occurs within 24 hours after ascend-
ing to 2500 m or higher [2]. HAH affects tourists’ and
labor workers’ daily life and work due to its high inci-
dence and discomfort experience [3]. HAH has also been* Correspondence: huanglan260@126.com
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mountain sickness [4].
Over the past several decades, epidemiology, clinical
characteristics, risk factors, prevention and treatment as-
pects of HAH have been systematically studied in moun-
taineers [5, 2, 6, 7]. Clinical characteristics studies have
showed that HAH presents as a sudden attack of mi-
graine that is accompanied by nausea [6]. Previous stud-
ies have demonstrated that increased heart rate (HR)
and self-anxiety scores, lower saturation pulse oxygen
(SpO2) and a history of primary headache are all inde-
pendent risk factors for HAH [8, 9]. Though oxygen in-
halation, acetaminophen and aspirin have been used toOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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11]. Despite accumulating evidence regarding HAH and
related issues, the underlying mechanisms remain elu-
sive [12, 13, 1].
HAH exhibits an impulsivity property [14], which may
be related to the hemodynamics (or blood flow in artery)
of patients. While most previous studies have focused on
the risk factors and epidemiology of HAH, few of them
give proper attentions to the hemodynamic characteristics
of HAH [8, 9, 7]. Furthermore, most of these studies have
been conducted in mountaineers, which may not reflect
representative properties of HAH [5, 9, 12].
To the best of our knowledge, the hemodynamic charac-
teristics of and their roles in HAH has not been fully
uncovered. Thus, we postulate that hemodynamics espe-
cially cerebral hemodynamic parameters are related HAH
and they may be predictors for HAH. Therefore, we per-
formed this large sample size cohort study to explore the
hemodynamic characteristics of HAH via examinations of
the systemic and cerebral hemodynamic parameters using
echocardiogram and transcranial Doppler sonography, re-
spectively, following acute high altitude exposure (within
24 h after arrival at 3700 m) to facilitate our understand-
ing of the disease process and provide insight into the spe-




Three hundred eighty-five participants were recruited in
June and July of 2012 according to specific inclusion and
exclusion criteria. The inclusion criteria were as follows:
healthy males between the ages of 18 and 60 years who
had no high-altitude exposure in recent two years. Individ-
uals with any of the following conditions were excluded:
neuropsychosis, cerebrovascular diseases, cardiovascular
diseases, respiratory diseases, malignant tumors and liver
or kidney disorders.
The study was reviewed and approved by the Ethics
Committee of Xinqiao Hospital of Third Military Medical
University. The study was thoroughly explained to all sub-
jects who agreed to participate, and all volunteers signed
informed consent forms prior to study participation.
Procedures
The subjects were transported to an altitude of 3700 m by
plane over two hours of travel in June and July of 2012.
None of the subjects drinks coffee regularly. The coffee,
tea, and other caffeine-containing drinks as well as alcohol
were avoided before the examinations. Baseline measure-
ments of systemic and cerebral hemodynamic parameters
were examined one week prior to the departure at sea
level (Chengdu, 500 m) in a subgroup of 129 participants.
The participants will receive regular training after a threedays’ rest. They did the daily life activities and avoided any
heavy exercises or physical labor in the first 72 hours at
3700 m. The field trials were performed within 18 to
24 hours after their arrivals at 3700 m. Structured case re-
port questionnaires were used to record the subjects’
demographic information (i.e., age, body mass index
(BMI), smoking and alcohol consumption), primary head-
ache history [None of them takes medication regularly
due to primary headache. However, severe headache
(HAH) subjects were treated with NSAIDs or Sanlietong
(Taiji medicine, Xi’an, China) as necessary at 3700 m] and
HAH symptoms (0 = no headache; 1 =mild headache; 2 =
moderate headache; 3 = severe headache).
Measurements of systemic hemodynamic parameters
The subjects’ systolic blood pressure (SBP), diastolic blood
pressure (DBP), HR and SpO2 were measured using a
sphygmomanometer (HEM-6200, OMRON, China) and a
pulse oximeter (NONIN-9550, Nonin Onyx, USA) after the
subjects had sat at rest for 30 min. Each subject received an
echocardiogram examination (ultrasonography system,
CX50, Philips, USA) that involved measurements of the
end-diastolic internal diameters of the left atrium (LA), left
ventricle (LV), right atrium (RA), right ventricle (RV) and
pulmonary artery (PA), in addition to the stroke volume
(SV), cardiac output (CO) and ejection fraction (EF).
Measurements of cerebral hemodynamic parameters
The examinations at both altitudes were performed in
the morning after an overnight fast and caffeine contain-
ing drinks were avoided.
Transcranial Doppler sonography examinations were
performed by the same technician using an ultrasonog-
raphy system with a 2 Hz probe (EME TC2021-III, NICO-
LET, USA). For each subject, the following parameters
were recorded: the mean velocity (Vm), systolic velocity
(Vs), diastolic velocity (Vd), pulsatility index (PI) and re-
sistance index (RI). These measurements were taken in
the bilateral middle cerebral artery (MCA) for anterior cir-
culation and in the vertebral artery (VA) and basilar artery
(BA) for posterior circulation.
The asymmetry of the MCA and VA was calculated as
ΔV = left velocity - right velocity for each lateral MCA
or VA, whereas the asymmetry index (AI) was calculated
as AI =ΔV/ [(left Vm + right Vm)/2]. The cerebrovascu-
lar conductance index was calculated as the Vm_MCA/
mean arterial blood pressure.
Statistical analysis
The case report forms were excluded if the demographic
information was not completed, the velocity could not
be identified at the depths previously described or the
systemic hemodynamic parameters were not measured.
Adjusted logistic regression
Independent predictors
Sea level (n = 129)
Univariate logistic regression
Differences between 
HAH+ and HAH- groups
3700 m (n = 363)





Fig. 1 The fluidogram of the statistical analysis
Bian et al. The Journal of Headache and Pain  (2015) 16:43 Page 3 of 13The normally distributed measurement variables (age,
BMI, SBP, DBP, SpO2, HR, echocardiography parameters
and velocities, PIs and RIs of the BA, MCAs and VAs)
were expressed as the mean ± standard deviation (SD).
The non-normally distributed variables were presented
as the medians (interquartile range). The enumerated
data are expressed as the rate of occurrence (%).
The normally distributed variables for the systemic
and cerebral circulation measurements were compared
using a paired Student’s t-test between the 500 and
3700 m altitudes and were analyzed using an independ-
ent samples t-test between the HAH positive (HAH+)
and HAH negative (HAH-) groups at both altitudes. The
asymmetries, AIs and tricuspid regurgitation measure-
ments were compared using a Mann–Whitney U test.
The relationships between HAH and the previously de-
scribed parameters at 500 m and 3700 m were analyzed
using Spearman’s correlations. Variables with a p < 0.05
in correlation analyses or significant difference between
HAH+ and HAH- groups were included in univariate lo-
gistic regression. Adjusted logistic analyses were used to
identify independent predictors or risk factors for HAH
after univariate logistic regression (Fig 1). Variables with
colinearity were analyzed in different models (adjusted
by primary variables or calculated variables respectively)
to reduce the bias.
The statistical analyses were performed using SPSS 19.0
software for Windows. P ≤ 0.05 was considered statistically
significant. Statisticians from Third Military Medical Uni-
versity were consulted regarding the statistical methods
and results.
Results
Clinical characteristics of the subjects
Three hundred eighty-five subjects received both echocar-
diography and transcranial Doppler examinations at
3700 m of elevation (363 subjects had completely valid
transcranial Doppler and echocardiography parameters).
Baseline measurements at 500 m were also recorded
among 129 individuals. The subjects in this study were
characterized by a mean age of 23.35 ± 4.37 years and a
mean BMI of 21.81 ± 2.50 kg/m2. The ethnicity of the
population was primarily Han Chinese (83.2%). Overall, in
our study, the incidence of HAH following acute exposure
to 3700 m was 75.2% (273 of 363).
Alterations in systemic and cerebral hemodynamics
Both systemic and cerebral circulations were dramatic-
ally altered following acute exposure to high altitude
from sea level. However, the blood pressure parameters,
including the SBP, DBP, pulse pressure and mean arterial
blood pressure, did not significantly increase after the
acute exposure. The SpO2 decreased from 98.34 ± 1.06%
to 88.72 ± 2.71% (p < 0.001). The LA, RA and RV allsignificantly decreased (all p < 0.001). However, the EF and
CO significantly increased, as well as the velocity in the
bilateral MCAs. In VAs and BA, the Vd exhibited a signifi-
cant increase. However, the VAs asymmetries did not
dramatically change. The changes in the hemodynamic
parameters are summarized in Table 1.
Clinical and hemodynamic characteristics of HAH at
3700 m
Only age (p = 0.044) was significantly higher in the HAH+
group as compared with the HAH- group regarding
demographic data. The HAH+ patients were characterized
by increased HR (87.96 ± 13.02 vs. 84.41 ± 13.11 beats per
min, p = 0.026) and decreased SpO2 (87.94 ± 3.19 vs.
88.70 ± 2.98%, p = 0.048). Regarding blood pressure, there
was no significant difference between the HAH+ and
HAH- groups in the SBP, DBP, pulse pressure or mean ar-
terial blood pressure. Although the LA, LV, RA, RV, PA,
Table 1 Alterations in systemic and cerebral hemodynamics (N = 129)
Sea level 3700 m p value
Systemic hemodynamics
SBP 116.32 ± 15.24 115.84 ± 11.84 0.782
DBP 74.65 ± 10.93 76.24 ± 9.40 0.156
ΔBP 41.67 ± 11.71 39.61 ± 8.05 0.131
MAP 88.54 ± 11.25 89.44 ± 9.55 0.444
HR 63.58 ± 10.19 83.98 ± 11.90 <0.001**
SpO2 98.34 ± 1.06 88.72 ± 2.71 <0.001**
LA 30.91 ± 1.73 30.00 ± 1.92 <0.001**
LV 46.47 ± 2.45 46.15 ± 2.04 0.184
RA 35.70 ± 2.23 34.21 ± 2.15 <0.001**
RV 35.49 ± 2.08 33.72 ± 2.42 <0.001**
PA 20.24 ± 1.60 19.92 ± 1.60 0.097
EF 62.94 ± 5.49 66.56 ± 3.92 <0.001**
SV 65.24 ± 12.22 67.30 ± 8.31 0.088
CO 4.16 ± 0.95 5.32 ± 1.09 <0.001**
Tricuspid regurgitation 0.500 (1.00) 0.500(0.500) 0.885
Cerebral hemodynamics
Left side MCA
Vm 62.08 ± 10.39 65.79 ± 11.78 <0.001**
Vs 95.95 ± 14.60 99.80 ± 15.93 0.002**
Vd 42.69 ± 7.91 46.47 ± 9.07 <0.001**
PI 0.867 ± 0.133 0.817 ± 0.133 <0.001**
RI 0.554 ± 0.048 0.534 ± 0.048 <0.001**
Left side VA
Vm_ 32.77 ± 5.14 35.20 ± 5.83 <0.001**
Vs_ 50.70 ± 7.50 51.57 ± 7.91 0.233
Vd_ 21.91 ± 4.095 24.82 ± 4.86 <0.001**
PI 0.895 ± 0.181 0.770 ± 0.168 <0.001**
RI 0.570 ± 0.067 0.516 ± 0.061 <0.001**
Right side MCA
Vm 58.79 ± 10.18 63.25 ± 11.58 <0.001**
Vs 90.50 ± 14.18 94.71 ± 15.01 <0.001**
Vd 40.35 ± 7.49 44.55 ± 9.04 <0.001**
PI 0.864 ± 0.150 0.804 ± 0.130 <0.001**
RI 0.556 ± 0.055 0.530 ± 0.050 0.293
Right side VA
Vm 34.33 ± 4.77 36.47 ± 5.73 <0.001**
Vs 50.60 ± 6.55 51.78 ± 7.83 0.058
Vd 23.24 ± 4.12 25.90 ± 4.55 <0.001**
PI 0.808 ± 0.162 0.715 ± 0.117 <0.001**
RI 0.539 ± 0.061 0.499 ± 0.048 <0.001**
BA
Vm 39.66 ± 7.75 41.85 ± 9.58 0.002**
Vs 67.93 ± 13.57 66.19 ± 13.46 0.117
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Table 1 Alterations in systemic and cerebral hemodynamics (N = 129) (Continued)
Vd 25.07 ± 5.85 28.59 ± 7.71 <0.001**
PI 1.093 ± 0.251 0.920 ± 0.220 <0.001**
RI 0.627 ± 0.068 0.567 ± 0.073 <0.001**
Asymmetry of the bilateral VAs
ΔVs 0.0 (11.0) 0.0 (12.0) 0.645
ΔVd −1.0 (6.0) −1.0 (6.0) 0.623
ΔVm −1.0 (7.0) −2.0 (8.0) 0.529
AI% −3.5 (20.2) −2.9 (18.1) 0.190
Conduction
CVCi 0.695 ± 0.145 0.730 ± 0.149 0.011*
BA: basilar artery; CO: cardiac output; CVCi : cerebrovascular conductance index; DBP: diastolic blood pressure; EF: ejection fraction; HAH: high-altitude headache;
HAH+: HAH positive or with HAH; HAH-: HAH negative or without HAH;HR: heart rate; LA: end-diastolic internal diameters of left atrium; LV: end-diastolic internal
diameters of left ventricle; MCA: middle cerebral artery; PA: end-diastolic internal diameters of pulmonary artery; PI: pulsatility index; RA: end-diastolic internal
diameters of right atrium; RI: resistance index; RV: end-diastolic internal diameters of right ventricle; SBP: systolic blood pressure;SpO2: saturation pulse oxygen;
SV: stroke volume; VA: vertebral artery; Vs: systolic velocity; Vd: diastolic velocity; Vm: mean velocity;ΔVs: difference in systolic velocity between bilateral isonym
cerebral arteries; ΔVd: difference in diastolic velocity between bilateral isonym cerebral arteries;ΔVm: Difference in mean velocity between bilateral isonym cerebral
arteries. Cerebrovascular conductance index (CVCi) = Vm_MCA/MAP
#: N = 129;
*p is 0.05 or less, **p is 0.01 or less
Most of the cerebral hemodynamic parameters altered dramatically from sea level to 3700 m and systemic hemodynamic parameters altered dramatically in part
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different in the HAH+ subjects compared with the HAH-
subjects (all p > 0.05), the CO was significantly increased
in the HAH+ group (p = 0.001).
Anterior circulation, which was assessed via measure-
ments of velocities in MCAs, was similar in the HAH+
and HAH- groups in bilateral MCAs (all p > 0.05). The
PIs and RIs in the right and left MCA were not different
between the two groups. For posterior circulation, the
velocities in BA, including Vs (65.46 ± 11.54 vs. 68.81 ±
14.84, p = 0.028), Vd (28.61 ± 7.46 vs. 30.47 ± 7.52, p =
0.042) and Vm (41.42 ± 8.64 vs. 44.18 ± 9.74, p = 0.017),
were significantly different in the HAH- group as com-
pared with the HAH+ group, respectively. Similar to the
MCA, the PI (p = 0.151) and RI (p = 0.292) of the BA
were not significantly different between the HAH+ and
HAH- groups. Furthermore, the Vd in left VA was signifi-
cantly increased in the HAH+ group compared with the
HAH- group (25.96 ± 4.97 vs. 24.76 ± 4.76 cm/s, p = 0.045),
whereas the Vs and Vm were not significantly different be-
tween the two groups. Additionally, the HAH+ patients
also exhibited a lower RI and PI in the left VA (p = 0.040
and 0.025, respectively). However, in the right VA, the
velocities and pulsate indexes showed no differences
between HAH+ group and HAH- one (all p > 0.05,
Table 2).
The asymmetry of the bilateral VAs, including the ΔVd
(p = 0.010), ΔVm (p = 0.046) and AI (p = 0.040), in the
HAH patients was significantly different than the HAH-
subjects. The cerebrovascular conductance index (0.724 ±
0.140 vs.0.729 ± 0.145, respectively, p = 0.758) was similar
in the HAH+ and HAH- subjects (Table 2).The Spearman’s correlation analyses demonstrated
that age (r = 0.178, p = 0.001), HR (r = 0.143, p = 0.006)
and CO (r = 0.175, p = 0.001) exhibited significantly posi-
tive relationships with the HAH severity, whereas the
SpO2 (r = −0.148, p = 0.005) exhibited an inverse relation-
ship. The other parameters in systemic hemodynamics
were not closely associated with HAH (all p > 0.05). The
anterior circulation parameters, including the velocities,
PIs and RIs in the bilateral MCA, had no associations with
HAH severity. With the exception of the Vs, the other pa-
rameters (Vm, Vd, PI and RI) of the BA exhibited signifi-
cant associations with HAH (p was 0.023, 0.021, 0.045
and 0.042, respectively). On the left side VA, the Vd
(r = 0.157, p = 0.003) and Vm (r = 0.120, p = 0.022) exhib-
ited positive relationships with HAH, whereas the PI
(r = −0.152, p = 0.004) and RI (r = −0.166, p = 0.001) were
negatively correlated with HAH. The parameters on the
right side of the VA were not as closely correlated with
HAH. Furthermore, associations between VA asymmetries
and HAH were also identified in the bilateral VAs: ΔV of
Vd (r = 0.137, p = 0.009), ΔV of Vm (r = 0.105, p = 0.046)
and AI (r = 0.106, p = 0.043). The relationships between
HAH and the hemodynamic parameters are shown in
Table 3.Risk factors for HAH at 3700 m
Univariate logistic regression was performed for variable
with a p < 0.05 in correlation analyses or significant dif-
ference between HAH+ and HAH- groups. HR, SpO2,
CO, Vd, PI and RI of left side VA, velocities in BA (Vm,
Vd) and ΔVd were risk factors for HAH. After adjusted
Table 2 Differences between HAH+ and HAH- groups in demographics, systemic and cerebral hemodynamics (N = 363)
Headachea HAH- HAH+ HAH intensities p (H+ vs. H-)
Cases(n) (90) (273) Mild (215) Moderate (52) Sever (6)
Demographic factors
Age 22.59 ± 3.95 23.60 ± 4.48 23.12 ± 4.26 25.47 ± 4.99 25.00 ± 3.69 0.044*
BMI 21.52 ± 2.11 21.90 ± 2.61 21.85 ± 2.55 21.96 ± 2.89 23.56 ± 2.09 0.199
Smoking(yes) 20(22.2%) 66(24.2%) 52(24.2%) 11(21.2%) 3(50.0%) 0.705
Alcohol consumption(yes) 54(60.0%) 159(58.2%) 126 (58.6%) 28(53.8%) 5(83.3%) 0.796
Systemic hemodynamics
SBP 117.28 ± 11.62 118.66 ± 12.03 118.84 ± 12.38 118.17 ± 11.04 116.67 ± 7.76 0.340
DBP 77.52 ± 10.83 78.86 ± 9.97 78.89 ± 10.21 78.92 ± 9.26 77.33 ± 8.43 0.279
ΔBP 39.76 ± 7.14 39.80 ± 6.59 39.94 ± 7.04 39.25 ± 4.54 39.33 ± 5.24 0.958
MAP 90.77 ± 10.57 92.13 ± 10.24 92.21 ± 10.47 92.01 ± 9.65 90.44 ± 7.83 0.280
HR 84.41 ± 13.11 87.96 ± 13.02 87.35 ± 12.65 89.35 ± 13.26 98.00 ± 20.66 0.026*
SpO2 88.70 ± 2.98 87.94 ± 3.19 88.16 ± 3.01 87.06 ± 3.81 87.83 ± 3.06 0.048*
LA 29.82 ± 2.12 29.70 ± 2.18 29.75 ± 1.99 29.40 ± 2.84 30.33 ± 2.50 0.632
LV 45.78 ± 2.27 46.00 ± 2.25 46.04 ± 2.21 45.85 ± 2.44 45.83 ± 2.32 0.425
RA 33.98 ± 2.04 34.10 ± 2.32 34.14 ± 2.27 34.06 ± 2.56 33.17 ± 2.32 0.661
RV 33.48 ± 2.24 33.70 ± 2.56 33.78 ± 2.56 33.50 ± 2.60 32.50 ± 2.07 0.469
PA 19.83 ± 1.14 19.95 ± 1.42 19.93 ± 1.42 19.98 ± 1.48 20.33 ± 1.03 0.452
EF 66.38 ± 4.28 67.16 ± 4.72 67.29 ± 4.82 66.87 ± 4.40 64.83 ± 3.31 0.165
SV 65.92 ± 8.96 67.32 ± 9.72 67.57 ± 9.79 66.66 ± 9.42 64.17 ± 10.63 0.230
CO 5.16 ± 1.14 5.60 ± 1.02 5.60 ± 1.03 5.65 ± 1.02 5.60 ± .663 0.001**
Tricuspid regurgitation 0.50(0.80) 0.50(0.60) 0.50(0.60) 0.50(0.80) 0.40(0.68) 0.135
Cerebral hemodynamics
Left side MCA
Vm 67.46 ± 12.18 67.41 ± 11.74 66.91 ± 10.87 69.35 ± 14.87 68.50 ± 11.47 0.973
Vs 102.17 ± 14.94 101.41 ± 15.91 100.79 ± 15.15 103.92 ± 18.83 102.00 ± 15.82 0.693
Vd 48.0 ± 10.12 47.96 ± 9.10 47.51 ± 8.37 49.46 ± 11.67 51.00 ± 8.60 0.964
PI 0.820 ± 0.169 0.800 ± 0.130 0.802 ± 0.127 0.799 ± 0.141 0.750 ± 0.130 0.260
RI 0.531 ± 0.063 0.527 ± 0.0490 0.528 ± 0.048 0.526 ± 0.051 0.499 ± 0.057 0.532
Left side VA
Vm 35.18 ± 5.57 36.38 ± 6.19 35.93 ± 5.66 37.63 ± 6.59 41.67 ± 14.40 0.103
Vs 51.28 ± 7.05 52.16 ± 8.49 51.75 ± 7.93 53.19 ± 9.20 57.83 ± 17.59 0.374
Vd 24.76 ± 4.76 25.96 ± 4.97 25.46 ± 4.49 27.35 ± 5.08 32.00 ± 11.93 0.045*
PI 0.765 ± 0.159 0.727 ± 0.153 0.738 ± 0.153 0.690 ± 0.150 0.640 ± 0.102 0.040*
RI 0.517 ± 0.065 0.500 ± 0.061 0.505 ± 0.058 0.482 ± 0.070 0.454 ± 0.053 0.025*
Right side MCA
Vm 63.51 ± 13.67 64.46 ± 11.45 64.24 ± 11.26 64.87 ± 11.57 68.67 ± 17.61 0.518
Vs 95.59 ± 17.61 96.24 ± 15.67 96.17 ± 15.55 96.13 ± 15.65 99.83 ± 22.29 0.740
Vd 45.11 ± 10.96 45.75 ± 8.73 45.53 ± 8.52 46.12 ± 8.95 50.67 ± 13.74 0.573
PI 0.812 ± 0.144 0.792 ± 0.124 0.796 ± 0.121 0.780 ± 0.125 0.734 ± 0.190 0.191
RI 0.530 ± 0.053 0.526 ± 0.051 0.527 ± 0.051 0.521 ± 0.047 0.493 ± 0.076 0.440
Right side VA
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Table 2 Differences between HAH+ and HAH- groups in demographics, systemic and cerebral hemodynamics (N = 363) (Continued)
Vm 37.27 ± 6.18 37.27 ± 6.02 37.00 ± 5.80 38.63 ± 6.89 35.17 ± 4.66 0.991
Vs 52.51 ± 7.69 52.26 ± 8.29 52.11 ± 8.09 53.42 ± 9.21 47.50 ± 6.06 0.800
Vd 26.72 ± 5.09 26.55 ± 4.74 26.26 ± 4.56 27.75 ± 5.33 26.33 ± 4.89 0.764
PI 0.716 ± 0.208 0.693 ± 0.117 0.702 ± 0.117 0.669 ± .114 0.606 ± 0.056 0.202
RI 0.500 ± 0.119 0.491 ± 0.053 0.494 ± 0.052 0.480 ± .053 0.448 ± 0.037 0.317
BA
Vm 41.42 ± 8.64 44.18 ± 9.74 43.80 ± 9.42 46.33 ± 10.91 38.83 ± 8.06 0.017*
Vs 65.46 ± 11.54 68.81 ± 14.84 68.60 ± 14.32 70.81 ± 16.13 59.17 ± 19.63 0.028*
Vd 28.61 ± 7.46 30.47 ± 7.52 30.07 ± 7.31 32.29 ± 8.31 28.83 ± 6.27 0.042*
PI 0.914 ± 0.224 0.879 ± 0.193 0.890 ± 0.192 0.844 ± 0.183 0.760 ± .262 0.151
RI 0.564 ± 0.078 0.554 ± 0.068 0.559 ± 0.066 0.542 ± 0.069 0.496 ± .086 0.292
Asymmetry of the bilateral VAs
ΔVs −1.00 (8.00) 0. 00 (9.00) 0.00(9.00) 0.00 (10.50) 5.00 (28.5) 0.126
ΔVd −3.00 (6.25) −1.00 (6.00) −1.00(7.00) −1.00 (3.75) 2.00 (18.5) 0.010*
ΔVm −2.50 (8.00) −1.00 (6.00) −1.00(6.00) −1.00 (4.75) 1.00 (23.75) 0.046*
AI% −6.6(22.0) −2.7 (18.0) −2.9(18.4) −2.1(13.8) 2.8 (52.2) 0.040*
Conduction
CVCi 0.729 ± 0.145 0.724 ± 0.140 0.719 ± 0.135 0.737 ± 0.153 0.767 ± 0.191 0.758
*p is 0.05 or less, **p is 0.01 or less
HAH was characterized with higher velocity in posterior cerebral circulation and higher HR but lower SpO2
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dependent risk factors for HAH (Table 4).Associations between hemodynamic parameters and HAH
in a subgroup of 129 subjects
In the baseline parameters, CO, Vm, PI and RI in left side
VA, velocities [Vm (60.20 ± 10.37 vs. 54.29 ± 7.03 cm/s,
p = 0.004), Vs (92.11 ± 14.53 vs. 85.64 ± 10.46 cm/s,
p = 0.023) and Vd (41.42 ± 7.60 vs. 37.19 ± 5.50 cm/s,
p = 0.005)] in right MCA were significant different
between HAH+ and HAH- groups. Furthermore, CO
showed a positive relationship with HAH (Table 5).
Univariate logistic regression revealed that CO, Vm in
both VAs and velocities in right side MCA were risk fac-
tors for HAH. However, adjusted analyses showed that
CO (adjusted by Vs and Vd of right side MCA, OR:
1.613, p = 0.036 or adjusted by Vm of right side MCA
OR: 1.811, p = 0.024) and Vm in right MCA (OR: 1.066,
p = 0.011) or left VA (OR: 1.099, p = 0.035) were still in-
dependent predictors for HAH (Table 6).
Furthermore, in the subgroup analysis, the change in tri-
cuspid regurgitation from sea level to 3700 m was sig-
nificantly different between the HAH+ and HAH-
groups. The alterations of ΔV in Vd and Vs of the VAs
and the Vm and Vd of the BA were also significantly
different between the HAH+ and HAH- groups (see
Additional file 1: Table S1A).Discussion
Alterations in both systemic and cerebral hemodynamics
In the current study, we identified alterations in both
systemic and cerebral hemodynamics. The HR dramatic-
ally increased between sea level and high altitudes,
which is consistent with a previous study that reported a
significant increase in HR after exposure to high altitude
because of the activation of the parasympathetic nervous
system by hypobaric hypoxic stress [15, 4, 16]. However,
the SV was similar at both altitudes, which indicates the
increased CO was primarily caused by the increased HR
[16]. Conversely, the hypoxia also induced a reduction in
the SpO2, which may result in a decrease in the delivery
of oxygen and energy to organs and tissues. Further-
more, the diastolic function of the heart has been re-
ported to decrease in high altitude environments, which
may be because of the shortened cardiac diastolic phase
caused by the increased HR [17, 16].
Following acute hypoxic stress, parasympathetic ner-
vous system activation, combined with a disequilibrium in
the synthesis and expression of certain vasoconstrictors
and vasodilators, results in endothelial cell dysfunction
(e.g., increased endothelin-1 expression vs. decreased ni-
tric oxide level) [18, 19]. Therefore, the vasoconstriction
of systemic and cerebral arteries exhibits a significant im-
pact on the measured velocities of blood flow [20]. We
demonstrated that most velocities in both the anterior and
posterior cerebral circulations significantly increased.
Table 3 Relationships between HAH and demographic, systemic and cerebral hemodynamic parameters (N = 363)
Headache score
r p r p
Demographic factors PI −0.152 0.004**
Age 0.178 0.001** RI −0.166 0.001**
BMI 0.075 0.155
Right side MCA
Systemic hemodynamics Vm 0.078 0.136
SBP 0.031 0.561 Vs 0.055 0.297
DBP 0.031 0.560 Vd 0.086 0.103
ΔBP 0.009 0.865 PI −0.099 0.059
MAP 0.033 0.535 RI −0.087 0.097
HR 0.143 0.006**
SpO2 −0.148 0.005** Right side VA
LA −0.035 0.507 Vm 0.039 0.455
LV 0.027 0.610 Vs <0.001 0.997
RA 0.010 0.851 Vd 0.036 0.499
RV 0.001 0.992 PI −0.083 0.115
PA 0.058 0.275 RI −0.065 0.215
EF 0.045 0.390
SV 0.035 0.506 BA
CO 0.175 0.001** Vm 0.119 0.023*
Tricuspid regurgitation 0.044 0.400 Vs 0.077 0.141
Vd 0.121 0.021*
Cerebral hemodynamics PI −0.105 0.045*
Left side MCA RI −0.107 0.042*
Vm 0.033 0.536
Vs 0.018 0.733 Asymmetry of VAs
Vd 0.039 0.454 ΔVs 0.080 0.130
PI −0.039 0.458 ΔVd 0.137 0.009**
RI −0.050 0.345 ΔVm 0.105 0.046*
AI% 0.106 0.043*
Left side VA
Vm 0.120 0.022* Conduction
Vs 0.067 0.203 CVCi 0.019 0.716
Vd 0.157 0.003**
*p is 0.05 or less, **p is 0.01 or less
HAH was positively associated with HR, CO and cerebral velocities while it negatively correlated with SpO2, PIs and RIs in BA and left side VA
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bral blood flow increased dramatically after high altitude
exposure [21–23].
Associations between HAH occurrence and
demographical data
As previously reported by our team and other re-
searchers, HAH patients are typically older in age, which
is consistent with the risk factors of primary headache atsea level and high altitude [8, 9]. Although a history of
smoking and alcohol consumption did not exhibit asso-
ciations with HAH, they were not precisely measured,
which could be improved in future studies.
HAH is partially associated with systemic hemodynamics
HAH is a regional symptom that comprises the primary
diagnostic criteria of acute mountain sickness, which is
typically induced by a local and systematic factor [5, 24].
Table 4 Univariate and adjusted logistic regression for variables










HR 0.022 1.022 1.003 1.042 0.027*
SpO2 −0.081 0.922 0.851 1.000 0.049*
CO 0.422 1.524 1.195 1.944 0.001**
Left VA Vd 0.052 1.053 1.001 1.108 0.046*
PI −1.562 0.210 0.047 0.944 0.042*
RI −4.476 0.011 0.000 0.591 0.026*
BA Vm 0.032 1.033 1.005 1.061 0.018*
Vd 0.044 1.036 1.001 1.071 0.035*
Asymmetry of VAs ΔVd 0.063 1.065 1.011 1.122 0.018*
Adjusted logistic regression
Model 1
HR 0.025 1.025 1.005 1.045 0.012*
Model 2
HR 0.023 1.023 1.003 1.044 0.026*
ΔVd 0.065 1.068 1.013 1.126 0.015*
Model3
CO 0.417 1.517 1.189 1.937 0.001**
ΔVd 0.063 1.065 1.009 1.124 0.022*
*p is 0.05 or less, **p is 0.01 or less
Model 1: Adjusted by primary variables (SpO2, Vd in left side VA and BA);
Model 2: Adjusted by primary variables and an asymmetry data (ΔVd);
Model 3: Avoided the colinearity between HR and CO, indicated that CO and
ΔVd were independent risk factors for HAH;
We just listed the variable with a p < 0.05
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HAH because it functions to deliver blood to all organs,
including the brain, which is an organ with considerably
high metabolism and energy consumption. First, an in-
creased HR exhibited a strongly positive correlation with
HAH, which is consistent with the relationship between
CO and HAH. The HAH patients were also character-
ized by increased HR and CO. Further analyses indicated
that baseline CO and LV were correlated with HAH sig-
nificantly. These results may be because of the nervous
system changes that lead to alterations in systemic
hemodynamics [19, 25, 16]. In addition, the SpO2 was
inversely correlated with HAH; however, the SBP and
DBP were not related to HAH, which was similar to pre-
vious studies [8, 15, 25]. A reduced SpO2 and increased
HR are independent risk factors for HAH [8, 9]. These
changes could result from sympathetic nervous system
activation and a decreased partial pressure of oxygen,
which results in a decrease in oxygen delivery to the
brain, where oxygen consumption is increased during
hypoxic stress [5, 9, 6]. The change in tricuspid regurgi-
tation in HAH patients differed from the non-HAHsubjects, which indicates alterations in cardiac function
induced by hypoxia may be risk factors for HAH (see
Additional file 1).
Cerebral hemodynamic characteristics of HAH
In the present study, we demonstrated that the velocities
in both the BA and left VA in the posterior cerebral cir-
culation were strongly associated with HAH, which is
partly consistent with previous reports [26, 22, 27]. The
HAH patients were characterized by an increased Vd but
decreased RI and PI in the left VA. These findings imply
that HAH is associated with higher blood flow but lower
resistance and compliance. At the baseline, HAH+ pa-
tients were also featured with a higher Vm in VAs on
both sides indicating that posterior circulation plays crit-
ical roles in HAH or it is a pathophysiological process of
HAH. Furthermore, the HAH+ group also exhibited in-
creased Vs and Vd in the BA, which supplies blood and
oxygen to the cerebellum. These results are consistent
with the clinical characteristics that HAH often presents
(i.e., a pulsing headache), which may be caused by dia-
stolic dysfunction in the arteries [5, 6]. The relationship
between HAH and posterior, rather than anterior, cere-
bral circulation contributed to HAH occurrence.
Of note, velocities in right MCA at baseline in HAH+
group were differed significantly from those in HAH-
group. In partial agreement with the results reported for
acute mountain sickness, including HAH, we did not
identify an association between HAH and anterior circula-
tion as assessed by the velocities, PI and RI of the bilateral
MCAs [28]. However, these results were inconsistent with
the previously reported that acute mountain sickness re-
lated headache usually presents as frontal headache [5].
The inconsistence may be caused by the sample size in
the subgroup of 129 participants.
Though the baseline conduction from systemic to
cerebral blood flow, which was evaluated using the cere-
brovascular conductance index, showed a significant dif-
ference between HAH+ and HAH- groups, it is not
predictor for HAH. Furthermore, it was not associated
with HAH at 3700 m, which indicates cerebral blood
flow plays a primary role in HAH and has more critical
importance than systemic hemodynamics.
Predictors and risk factors for HAH
After adjusted regression analyses at baseline, we identi-
fied that CO and Vm in left VA (or right MCA in differ-
ent regressions) were independent predictors for HAH.
However, the posterior and anterior circulations were
not valuable in a same model.
Other adjusted analyses at 3700 m revealed that only
HR (or CO) and ΔVd were independent risk factors for
HAH, which is partly consistent with our and others’
previous studies. However, ΔVd was found to be a novel
Table 5 Associations between baseline parameters and HAH (N = 129)
Differences between HAH+ Correlation with HAH intensities
and HAH- groups
Headache Cases(n) HAH-(31) HAH+(98) p value r p value
Demographic factors
Age 22.71 ± 3.21 23.13 ± 4.31 0.616 0.093 0.297
BMI 21.41 ± 1.67 22.07 ± 2.52 0.175 0.153 0.084
Smoking(yes) 7(22.5%) 23(23.5%) 0.919 / /
Alcohol consumption(yes) 21(67.7%) 58(59.2%) 0.396 / /
Primary headache(yes) 4(12.9%) 23(23.5%) 0.209 / /
Systemic hemodynamic
SBP 118.35 ± 10.81 117.32 ± 12.37 0.676 0.018 0.843
DBP 74.00 ± 9.22 75.18 ± 11.31 0.598 0.059 0.509
ΔBP 44.35 ± 6.47 42.13 ± 6.37 0.094 −0.137 0.122
MAP 88.78 ± 9.29 89.22 ± 11.28 0.843 0.061 0.490
HR 63.32 ± 11.35 64.42 ± 10.10 0.607 0.008 0.930
SpO2 98.35 ± 1.02 98.30 ± 1.10 0.793 0.038 0.670
LA 31.06 ± 1.55 30.87 ± 1.78 0.581 −0.062 0.484
LV 45.81 ± 2.14 46.71 ± 2.50 0.071 0.183 0.037*
RA 35.45 ± 1.98 35.78 ± 2.27 0.478 0.153 0.082
RV 35.29 ± 1.85 35.55 ± 2.13 0.542 0.109 0.217
PA 20.06 ± 1.46 20.30 ± 1.63 0.481 0.094 0.288
EF 62.90 ± 5.98 63.10 ± 5.34 0.865 0.002 0.978
SV 62.53 ± 16.31 66.55 ± 10.61 0.113 0.088 0.322
CO 3.79 ± 1.01 4.33 ± 0.93 0.007** 0.177 0.045*
Tricuspid regurgitation 0.50(1.00) 0.45(1.00) 0.372 −0.030 0.739
Cerebral hemodynamic
Left side MCA
Vm 59.61 ± 8.24 63.24 ± 10.92 0.091 0.060 0.501
Vs 93.48 ± 12.13 97.00 ± 15.21 0.246 0.062 0.488
Vd 40.93 ± 6.20 43.62 ± 8.37 0.102 0.058 0.513
PI 0.889 ± 0.154 0.852 ± 0.125 0.180 −0.004 0.960
RI 0.562 ± 0.051 0.550 ± 0.047 0.221 −0.015 0.862
Left side VA
Vm 30.94 ± 5.25 33.23 ± 4.97 0.029* 0.171 0.053
Vs 49.64 ± 7.11 50.82 ± 7.56 0.444 0.083 0.351
Vd 20.68 ± 4.17 22.26 ± 3.95 0.056 0.142 0.107
PI 0.957 ± 0.193 0.873 ± 0.169 0.022* −0.150 0.090
RI 0.594 ± 0.075 0.561 ± 0.056 0.010* −0.159 0.072
Right side MCA
Vm 54.29 ± 7.03 60.20 ± 10.37 0.004** 0.155 0.080
Vs 85.64 ± 10.46 92.11 ± 14.53 0.023* 0.125 0.157
Vd 37.19 ± 5.50 41.42 ± 7.60 0.005** 0.114 0.200
PI 0.888 ± 0.150 0.855 ± 0.146 0.276 −0.078 0.380
RI 0.574 ± 0.062 0.586 ± 0.053 0.592 −0.093 0.292
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Table 5 Associations between baseline parameters and HAH (N = 129) (Continued)
Right side VA
Vm 32.77 ± 5.30 34.84 ± 4.40 0.032 0.126 0.155
Vs 49.38 ± 6.88 51.03 ± 6.33 0.220 0.073 0.411
Vd 22.09 ± 4.29 23.64 ± 3.95 0.065 0.110 0.216
PI 0.849 ± 0.160 0.793 ± 0.156 0.086 −0.141 0.110
RI 0.555 ± 0.055 0.534 ± 0.061 0.081 −0.134 0.130
BA
Vm 37.55 ± 7.36 40.50 ± 7.80 0.065 0.154 0.082
Vs 66.29 ± 13.65 68.53 ± 13.87 0.433 0.054 0.546
Vd 23.48 ± 5.08 25.69 ± 5.97 0.066 0.139 0.115
PI 0.964 ± 0.210 0.885 ± 0.197 0.092 −0.104 0.239
RI 0.644 ± 0.055 0.621 ± .0714 0.108 −0.074 0.404
Asymmetry of bilateral VAs
ΔVs 2.0 (15.0) 0.0(9.25) 0.795 0.042 0.634
ΔVd 0.0(6.0) −2.0 (6.0) 0.703 0.017 0.851
ΔVm −2.0 (8.0) −1.0 (7.0) 0.934 0.064 0.468
AI% −0.061 (0.224) −0.034(0.200) 0.815 0.075 0.398
Conduction
CVCi 0.648 ± 0.103 0.704 ± 0.145 0.048* 0.097 0.275
/:binary variables that were not analyzed by Spearman’s correlation
*p is 0.05 or less, **p is 0.01 or less
Table 6 Univariate and adjusted logistic regression for variables








CO 0.650 1.915 1.158 3.168 0.011*
Left side VA Vm 0.095 1.099 1.008 1.198 0.031*
Right side MCA Vm 0.071 1.073 1.021 1.127 0.005**
Vs 0.039 1.040 1.005 1.076 0.026*
Vd 0.087 1.091 1.024 1.161 0.007**
Right side VA Vm 0.099 1.104 1.007 1.211 0.035*
Adjusted logistic regression
Model 1
Left VA Vm 0.094 1.099 1.007 1.199 0.035*
CO 0.478 1.613 1.031 2.522 0.036*
Model 2
Right side MCA Vm 0.064 1.066 1.015 1.121 0.011*
CO 0.594 1.811 1.080 3.036 0.024*
Model 1: Adjusted by primary variables (Vs and Vd of right side MCA)
Model 2: Adjusted by calculated variable (Vm of right side MCA)
Baseline CO was an independent predictor for HAH at 3700 m, whereas, Vm in
left VA or right MCA was also independent predictors for HAH in
different models
Only the variable with a significant statistically has been listed above
* p is 0.05 or less, ** p is 0.01 or less
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induced local expressions of vasoactive substances. Fur-
thermore, the variation in VAs of Chinese Han in anat-
omy may also be a reason for our findings.Relationship between HAH and VA asymmetry
We report a novel finding in that VA asymmetry was
closely related to HAH. An asymmetry in the bilateral
isonym VA exists under normal physiological conditions
[21, 28, 29]. However, this physiological asymmetry
could become a considerable or pathological irregularity
because of its amplification by hypoxia-induced vasodila-
tation and an impaired auto-regulation of cerebral blood
flow following acute high-altitude exposure [21].
Furthermore, HAH severity was closely associated with
the VA asymmetry, which represents a characteristic that
has not been previously reported. This finding may be as-
sociated with the region of blood flow and perfusion in
the cortex and cerebellum. It may also be related to the
clinical characteristics of the migraine pattern present in
many HAH patients [5]. The variance between the isonym
VAs may contribute to the development of HAH and re-
quires further examination to identify its precise patho-
physiological mechanisms.
HAH comprises multifactorial components [30, 12, 31,
14]. Therefore, the cerebral and systemic hemodynamic
characteristics of HAH may be relevant to the disease
Bian et al. The Journal of Headache and Pain  (2015) 16:43 Page 12 of 13development, as well as its pathophysiological processes
and clinical manifestations.
Limitations
Our study was restricted to young Chinese men, which
could potentially generate a bias regarding age or gender;
thus, this issue should be addressed in future studies. An-
other limitation is that a key modulator of cerebral perfu-
sion, partial pressure of carbon dioxide (PaCO2), was not
measured in the present study. This modulator could be
included in future mechanistic studies. Another limitation
is that headache satisfied the diagnostic criteria of the
International Classification of Headache Disorders basic-
ally. Although the descent was not performed immediately
after the onset of the headache, cephalalgia almost re-
solved as time went on. Furthermore, the subjects were all
newcomers from sea level, thus none of them with a his-
tory of HAH or acute mountain sickness history, which
should be improved in future study.
Conclusions
HAH is characterized, in part, by increased systemic
hemodynamics and posterior cerebral circulation as
reflected by the velocities in the BA and left VA, as well as
lower arterial resistance and compliance. Furthermore,
baseline CO and Vm in left VA or right MCA at sea level
are independent predictors for HAH, whilst bilateral VA
asymmetry may contribute to the development of HAH at
high-altitude.
Additional file
Additional file 1: Table S1A. Associations between changes of
hemodymics and HAH in the subgroup.
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